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Changes of the peritoneum can range in biological behav-
ior from benign to highly malignant. Peritoneal carcino-
matosis (PC) is the most common secondary tumor 
affecting the peritoneal cavity.1 Arising from malignant 
tumors of the gastrointestinal tract or the ovary, PC is 
associated with a poor prognosis. Cytoreductive surgery 
(CRS) followed by hyperthermic intraperitoneal chemo-
therapy (HIPEC) seems to be a treatment option for a 
group of highly selected patients suffering from PC, 
resulting in a significantly improved median survival.2,3 
Penetration of chemotherapeutic molecules during 
HIPEC is limited to 1 to 2 mm in depth.4 Therefore, 
resection of all tumor deposits greater than 2 mm in diam-
eter is essential. Optimal patient selection is mandatory, 
including early recognition and accurate assessment of 
the extent of PC.
For the diagnosis of PC, laparoscopy and biopsies of 
abnormal-appearing peritoneum are often part of the 
diagnostic workup. Laparoscopic detection of early 
malignant lesions on the peritoneal surface can be diffi-
cult because these foci can be subtle and flat. Because of 
limitations of conventional white-light laparoscopy 
(WL), it is frequently impossible to distinguish between 
malignant and benign peritoneal lesions. Improved imag-
ing techniques may help in more accurately predicting 
the histology of peritoneal lesions. The combination of 
autofluorescence imaging (AFI) and laparoscopy might 
be a promising step in this direction.
AFI is based on the fact that nonneoplastic and neo-
plastic tissues have different characteristics regarding 
their short-wavelength autofluorescence.5,6 This is based 
on differences in the proportion of endogenous fluoro-
phores (eg, tryptophan, collagen, and mitochondria) 
between normal and malignant tissue, resulting in a 
change in autofluorescent emission spectra.7-11 The epi-
thelial thickness of dysplastic/malignant tissue also influ-
ences autofluorescence emission.
AFI has been implemented in several medical fields. It 
is currently used for the detection of dysplastic lesions in 
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Abstract
Background and objectives. Autofluorescence imaging (AFI) is mainly used to detect (pre)cancerous colorectal and 
pulmonal lesions. This is the first report establishing the feasibility of AFI in patients with peritoneal carcinomatosis 
(PC). Methods. This is a prospective analysis of 10 patients undergoing conventional white-light laparoscopy (WL) and 
AFI for PC of different gastrointestinal tumors and 1 ovarian cancer. Before taking biopsies, suspicious peritoneal 
lesions were first detected by WL and then investigated by AFI. The intraoperative findings were photographed and 
then correlated with histological results. Results. Conventional WL and AFI evaluation was successful in all patients. 
A total of 38 biopsies were taken. The neoplasm detection rate under WL was 66% and increased to 86% when 
using AFI. The positive tumor detection rate was slightly higher in low AF lesions (83 vs 88%) and higher in tumor 
nodules (94%) than in flat peritoneal lesions (75%). For tumor nodules, the sensitivity was 94%, and the specificity 
was 100%. For flat lesions, the sensitivity was 75% and specificity 50%. Conclusions. We demonstrate the feasibility and 
effectiveness of AFI in patients with PC.
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patients with inflammatory bowel disease12-15 and has 
been used for the detection of nonpigmented endometri-
otic lesions.7 The visualization of reduced autofluores-
cence has proven advantageous in the diagnosis of 
precancerous and cancerous lesions in the bronchial tract 
and the bladder.16,17
Given these findings, we used AFI during laparoscopy 
in patients with PC. The aim was to evaluate the feasibil-
ity of AFI-augmented laparoscopy in the diagnosis of PC 
from different tumor entities. We also wanted to study 
whether the use of AFI laparoscopy helps differentiate 
normal from pathological peritoneal tissue and whether it 
helps in directing the biopsies taken during exploration.
Methods
Patients and Indications for Diagnostic 
Laparoscopy
The study was conducted between September 2010 and 
February 2011. The study population consisted of 3 men 
and 7 women. The median age was 53 years (range = 
46-71 years). The median body mass index (BMI) was 24 
(range 20-38).
Diagnostic laparoscopy was performed to confirm the 
clinically and/or radiologically suspected PC in 5 patients 
and to evaluate the distribution and potential resectability 
in all patients. One patient had cytological evidence of 
malignant ascites and 4 other patients had undergone a 
laparotomy or laparoscopy elsewhere for diagnostic pur-
poses. Therefore, the diagnosis of PC was already estab-
lished in these patients, but there was no complete 
description of the extent of the disease. Also, 8 patients 
had received systemic chemotherapy prior to presenta-
tion at our hospital. The primary origins of PC were gas-
tric cancer (n = 3), colon cancer (n = 5), ovarian cancer 
(n = 1), and suspected peritoneal recurrence of a benign 
mucinous cystadenoma of the appendix (n = 1). This 
patient had been treated 15 months before at our institu-
tion with a complete macroscopic cytoreduction (CCR-0) 
followed by an intraoperative HIPEC. The new histology 
from biopsies taken at diagnostic laparoscopy during this 
admission confirmed PC of a peritoneal mucinous carci-
nomatosis of the intermediate type (PMCA-I).18 Patient 
characteristics are given in Table 1.
Surgical Technique and AFI
Laparoscopy and CRS/HIPEC are performed at our 
clinic by the same team. Laparoscopic evaluation was 
done always as a separate procedure before CRS. 
Because of the laparoscopic results, the upcoming sur-
gery can better be discussed with the patient and the 
intraoperative and postoperative stress for the patient as 
well as the work load for the surgical team can be fore-
cast more precisely.
All laparoscopies were performed by 1 experienced sur-
geon. A 10-mm trocar was placed after minilaparotomy at 
the umbilicus and a pneumoperitoneum of 15 mm Hg was 
established. The laparoscope was inserted and a 5-mm tro-
car was inserted under direct vision. Atraumatic grasping 
forceps were used for examination. In view of planned 
subsequent CRS and HIPEC, only minor adhesiolysis was 
performed. The laparoscope used was equipped for a 
Table 1. Characteristics of the Patients.
Patient Sex Tumor Entity Surgery Prior to Our DL TNM Grading Last Chemotherapy Prior to DL
1 F GC DL + biopsy G3 FLOT
2 F GC Resection of a stenotic 
small-bowel loop
G3 DCF
3 F CC Left hemicolectomy pT3, pN1, M0, G3 FOLFOX
4 M CC Left hemicolectomy pT3, pN2, M0, G2 FOLFIRI + Avastin
5 F Mucinous cystadenoma, 
appendixa
CCR-0/HIPEC — —
6 F CC — G3 FOLFOX
7 F OC — G3 —
8 M GC Gastrectomy pT2b, pN1, M0, G3 FLOT
9 F CC Left hemicolectomy pT3, pN1, M0, G3 FOLFOX
10 M CC DL+ biopsy G3 FOLFOX
Abbreviations: F, female; M, male; GC, gastric cancer; CC, colon cancer; OC, ovarian cancer; DL, diagnostic laparoscopy; CCR-0, complete mac-
roscopic cytoreduction; HIPEC, hyperthermic intraperitoneal chemotherapy; FLOT, 5-fluorouracil, leukovorin, oxaliplatin, and docetaxel; DCF, 
docetaxel, cisplatin, 5-fluorouracil; FOLFOX, folinacid, 5-fluorouracil, oxaliplatin; FOLFIRI, folinacid, 5-fluorouracil, irinotecan; PC, peritoneal 
carcinomatosis.
aBecause of a mucinous cystadenoma of the appendix, patient no. 5 had been initially treated with a CCR-0/HIPEC. The histological result from 
biopsies taken from the recurrent tumor confirmed PC of a peritoneal mucinous carcinomatosis of the intermediate type (PMCA-I).18
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trimodal light source (Karl Storz GMBH&CO.KG 78532, 
Tuttlingen, Germany). It was connected to a video proces-
sor (Karl Storz GMBH&CO.KG 78532). One device of 
the laparoscope was used for conventional WL laparos-
copy, the other for AFI. The third device can be used for 
fluorescence diagnostics after systemic administration of a 
photosensitizer, but this was not done during this study. In 
AFI mode, excitation was performed by blue light, and a 
high-pass filter (500-630 nm) was used to detect AF emis-
sion. In this setting, green (528 nm) and red light (625 nm) 
can pass through the filter, whereas blue light (458 nm) is 
blocked. When illuminated with blue light, dysplastic and 
malignant lesions appear purple. The sequentially detected 
AF images were integrated by a processor resulting in a 
real-time image.19,20
Flat and nodular areas were observed first by conven-
tional WL, then via AFI. Before taking the biopsy, a photo 
of the region of interest was taken under WL and AFI to 
enable correlation of the intraoperative findings with the 
histological results.
Specimens were fixed in formalin, embedded in paraf-
fin, cut, stained with hematoxylin and eosin, and exam-
ined by an experienced pathologist.
Classification of Lesions Using AF
AF intensity of the peritoneal lesions was optically deter-
mined by the color of the areas. As reported by van den 
Broek et al,21 tissue appearing green under AFI is usually 
healthy tissue. Purple lesions were considered as poten-
tially malignant. Because of different color intensities of 
the purple lesions, we divided them into 2 groups. Light 
purple areas were regarded as having a high AF, suggest-
ing that this tissue might have less pathological changes. 
By contrast, dark purple areas were regarded as poten-
tially exhibiting major pathological changes. They were 
regarded as low AF. The intensity of the purple color 
under AFI was subjectively scored by the surgeon.
Sensitivity and Specificity
The matrix shown in Table 2 was used to calculate the 
sensitivity, specificity, positive predictive value, and neg-
ative predictive value. Histological results were com-
pared with the results from WL and AFI laparoscopy.
Ethical Considerations
This prospective study was approved by the local ethics 
committee (No. 11-101-0282). Procedures were done in 
accordance with the Declaration of Helsinki.
Results
Mortality and Morbidity
Conventional WL and AFI evaluation was successful in 
all 10 patients. The mean operating time was 48 minutes 
(range = 25-72 minutes). Laparoscopic abdominal explo-
ration and tissue sampling were well tolerated. No signifi-
cant blood loss was observed. One postoperative 
complication occurred in a patient with a BMI of 38. This 
patient noticed some pain next to a trocar wound on post-
operative day 2. Fascial closure of the abdominal wall 
proved to be insufficient, and the patient was reoperated 
on postoperative day 3, and the defect was repaired. The 
patient was discharged on postoperative day 6 without 
further complications. All other patients were discharged 
on postoperative day 2 or 3. The median length of hospital 
stay was 3 days.
Histology and Tumor Entities
A total of 38 laparoscopic biopsies were taken—at least 2 
biopsies per patient (range = 2-6). Histological validation 
was successful in 9 patients with clinical suspicion of PC. 
In 1 patient with a suspected recurrence of a benign muci-
nous cystadenoma of the appendix, the biopsies surpris-
ingly showed a PMCA-I.18 Apart from this patient, the 
tumor-positive biopsies always corresponded with the 
histology of the primary tumor.
Table 3 shows the morphology of lesions taken under 
suspicion of PC in WL or AFI mode and the histological 
detection rate. Under WL, 38 biopsies were taken from 
potentially malignant lesions. In WL mode, 25 of the 38 
biopsies were positive for malignancy (66%). In AFI 
mode, 29 of the 38 biopsies were suspicious for tumor, 
meaning that the whitish peritoneal lesions turned purple 
under AFI; 25 of these 29 suspicious areas were proved to 
be malignant. This resulted in a neoplasm detection rate 
of 86% using AFI. Of the 38 biopsies, 9 showed no color 
change, indicating fibrotic or necrotic peritoneal tissue. 
Table 2. Matrix for the Calculation of Sensitivity and Specificity for All Biopsies Taken Under AFI Guidance.
Patient With Tumor (rp+fn), n = 29 Patient Without Tumor (fp+rn), n = 8
AFI tumor positive (rp+fp), n = 29 Right positive (rp), n = 25 False positive (fp), n = 3
AFI tumor negative (fn+rn), n = 9 False negative (fn), n = 4 Right negative (rn), n = 5
Abbreviation: AFI, autofluorescence imaging.
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The histological evaluation of these 9 biopsies showed 
cancer in 4 of the 9 biopsies (44%; Table 3).
Classification of Lesions Using AF
The tumor detection rate was slightly higher in low-AF as 
compared with high-AF lesions (83 vs 88%). Moreover, 
the tumor-positive rate was higher in nodules (94%) com-
pared with flat peritoneal lesions (75%). The results are 
shown in Table 4.
Sensitivity and Specificity
For AFI, sensitivity was 25/29 (86%) and specificity 5/8 
(62.5%). The positive predictive value was 25/28 (0.89), 
and the negative predictive value 5/9 (0.55). In nodular 
lesions alone, we found a sensitivity of 16/17 (94%) and 
a specificity of 2/2 (100%). In flat lesions, the sensitivity 
was 9/12 (75%) and specificity 3/6 (50%).
Because all biopsies taken during WL laparoscopy 
were considered to be cancer positive, calculation of sen-
sitivity, specificity, and negative predictive value is 
impossible. The overall results of WL are 25/38 (0.65) for 
positive predictive value (Table 2).
Intraoperative Findings and Postoperative 
Consequence
Conventional WL and AFI evaluation of conspicuous 
peritoneal lesions was successful in all 10 patients. As 
shown in Figure 1, in the different gastrointestinal tumors 
and in the ovarian cancer, the AF of tumor-suspicious 
lesions resulted in a purple color change. AF images can 
be further processed. The ratio of green fluorescence and 
blue background fluorescence gives G/B values, which 
allow us to create pseudocolor images using ImageJ 
(http://rsbweb.nih.gov/ij/). This may ease the visual 
detection of tumors. However, this was not done during 
this study, and only a sample image is given (Supplemental 
Figure S1).
Out of the 10 patients, 6 were not selected for the CRS 
+ HIPEC procedure because of a diffuse tumor burden of 
the small intestine. Of the remaining patients, 3 underwent 
CCR-0 resection. In 1 patient, open surgery revealed 
lymph node metastases in the mesentery of the small intes-
tine and more intra-abdominal tumor load than expected, 
so that only palliative surgery could be performed.
Discussion and Conclusion
AFI has been implemented for detection of bronchial 
dysplasias and malignant tumors. These studies suggest 
that the use of fluorescence bronchoscopy in addition to 
conventional WL examination could significantly 
enhance the detection of bronchial lesions.22,23 AFI is a 
novel technology and may be a valuable tool for detection 
and diagnosis of colorectal neoplastic lesions during 
endoscopic examination of the gastrointestinal tract.13-15
Until now, AFI technology has never been used in 
patients with PC. Therefore, the objective of this study 
Table 4. Number of High- and Low-AF-Intensity Lesions.a
High AF Low AF Total (High and Low AF)
 n Tumor pos n Tumor pos n Tumor pos
Nodule lesion  6 6 11 10 17 16 (94%)
Flat lesion  6 4  6  5 12 9 (75%)
Total 12 10 (83%) 17 15 (88%)  
Abbreviations: AF, autofluorescence; pos, positive.
aCorrect identification of malignancy rate is more in nodules (94%) compared with flat peritoneal lesions (75%).
Table 3. Morphology and Histological Confirmation Rate of Suspicious Lesions Taken in White Light and Autofluorescence 
Mode.
Autofluorescence Mode
 White Light Mode Tumor Suspicious Not Tumor Suspicious
Morphology n n, Histo pos n, Histo pos n, Histo pos
Whitish color 38 25 (66%) 29, 25 (86%) 9, 4 (44%)
 Node 20 13 (65%) 17, 16 (94%) 3, 1
 Plane 18 12 (67%) 12, 9 (75%) 6, 3
Abbreviations: Histo, histology; pos, positive.
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was to evaluate the feasibility of adding AFI to WL in 
peritoneal metastases. Because the concept of the study 
was designed to evaluate the feasibility of AFI in PC, we 
compared the accuracy of detecting tumor-suspicious 
peritoneal lesions under WL and AF conditions. It was 
not the aim of this pilot study to identify any lesions 
missed under WL examination.
The correct prediction of the histological result was 
superior using AFI compared with WL only (86 vs 66%). 
These results agree with the higher detection rate of path-
ological lesions under AFI described in bronchoscopy, 
colonoscopy, and laparoscopy in patients with endome-
triosis.7,13,15,23,24 In all the 3 tumor entities as well as in the 
intermediate type I of the mucinous appendiceal tumor, 
tumor-positive spots could clearly be detected and biop-
sied in AF mode. AFI appears to offer potential for 
improving the detection rate of malignant foci in PC of 
colon, gastric, and ovarian cancer.
In the present investigation, the frequency of correct 
prediction of malignant histology was approximately bal-
anced under WL in nodular and flat peritoneal lesions 
(70% and 75%). Using AFI, 94% of the nodular lesions 
and only 75% of the flat lesions were correctly catego-
rized as malignant. Therefore, we suggest biopsy of nod-
ular areas rather than flat regions. Similar results were 
found in other studies of colonoscopy in patients with 
chronic inflammatory bowel disease.14,25,26
Regarding AF intensity, we found a trend toward 
higher prevalence of dysplasia in lesions with low AF 
than in those with high AF. This may partially be 
explained by the fact that in nodular areas, the tumor 
itself is thicker than in flat lesions. Thus, AF emission is 
rather low. Because 8 of the tumors were classified as G3, 
1 tumor as G2, and 1 tumor as intermediate type I, we are 
unable to state if low AF is correlated to higher tumor 
grading.
For all biopsies, sensitivity of AFI was 86% and speci-
ficity 62.5%. Both parameters clearly increased when 
only nodular lesions were evaluated (sensitivity = 94%; 
specificity = 100%). In contrast, sensitivity (75%) and 
specificity (50%) were lower in flat lesions. We conclude 
that AFI is useful in the detection of small tumor nodules. 
The reduced sensitivity and specificity in flat lesions war-
rants further study. Matsumoto et al14 found similar 
results for flat lesions in AFI colonoscopy with a good 
sensitivity but poor specificity. They speculated that AFI 
may identify active inflammation as well as neoplastic 
areas. Similar phenomena may have been present in our 
study. Therefore, it appears essential to verify the intraop-
erative tumor diagnosis by frozen section. The clinical 
evaluation of additional lesions may be improved after 1 
histologically positive nodule can be used as a compara-
tor. Selecting the correct nodule for biopsy is crucial in 
PC patients with suspicion of cancer of the small intes-
tine. Widespread involvement of the small intestine is the 
most frequent reason for considering a cancer as nonre-
sectable.27 In the case of histological verification of 
malignancy in 1 suspicious lesion using the AF mode, it 
Figure 1. Intraoperative findings using WL and AFI.a
Abbreviations: WL, white-light laparoscopy; AFI, autofluorescence imaging; PC, peritoneal carcinomatosis.
aIllustration of intraoperative pictures of PC under WL (first line) and corresponding pictures in AF mode (second line). Laparoscopic magnifica-
tion was 2.5-fold. AF pictures are corrected for contrast and tint in line 3. Columns of pictures (a), (b), and (c) are examples for PC from colon 
cancer with clear demarcation of tumor-involved areas in AF mode. Pictures (c) and (i) show partly nodular and partly flat peritoneal lesions. AFI 
shows partial tumor involvement. The column of picture (d) shows a diffuse whitish plane and thin peritoneal changes in a patient with gastric 
cancer. AF shows a clear demarcation of the potential tumor area. AF identification of a malignant process in an apparent adhesion in picture (e). 
The last column shows the abdominal wall with slight whitish peritoneal changes and ascites under WL (e) in a peritoneal mucinous carcinomato-
sis of the intermediate group. Improved visualization of pathological changes by AFI (l).
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is very probable that similar lesions under AF mode are 
also tumor positive. Therefore, small-bowel lesions can 
be correctly categorized without the risk of perforation 
after biopsy. Furthermore, the high sensitivity and speci-
ficity of the prediction of malignancy in tumor nodules 
evaluated using AFI may help in selecting informative 
areas for biopsy. This may reduce the number of biopsies 
needed and, thus, histopathological costs.
In our study, the time interval between chemotherapy 
and conventional WL and AFI evaluation was at least 2 
weeks. No sufficient data for an evidence-based state-
ment regarding the potential influence of chemotherapy 
on AFI exist. Probably chemotherapy would induce 
necrosis of tumor tissue resulting in white foci, which in 
turn would not be biopsied under AFI guidance.
Our data suggest that laparoscopy in patients with PC 
is a safe procedure, confirming evidence from other 
investigators.27-29 Adding AFI to the operative procedure 
most likely does not affect morbidity and mortality.
In summary, one potential application for WL and AFI 
may be early recognition of PC in asymptomatic patients 
at high risk for developing PC. Some authors reported 
more than 50% recurrences in the first year after CRS and 
perioperative intraperitoneal chemotherapy in such 
groups of patients.30,31 In these studies, PC was mostly 
diagnosed by laparotomy. In our opinion, WL in combi-
nation with AFI might be a better method to detect early 
inconspicuous PC in high-risk patients.
Laparoscopic AFI evaluation is feasible in patients with 
PC. The application of AFI in laparoscopy and proper inter-
pretation of the visual impressions requires training but 
facilitates real-time evaluation in most peritoneal lesions. 
The addition of AFI to WL may be a promising novel tech-
nology in the detection of neoplastic peritoneal foci. The 
results of this pilot study provide a rationale for further 
investigation of this technique in larger clinical trials.
Declaration of Conflicting Interests
The author(s) declared no potential conflicts of interest with 
respect to the research, authorship, and/or publication of this 
article. 
Funding
The author(s) received no financial support for the research, 
authorship, and/or publication of this article. 
References
 1. Levy AD, Shaw JC, Sobin LH. Secondary tumors and 
tumorlike lesions of the peritoneal cavity: imaging fea-
tures with pathologic correlation. Radiographics. 2009;29: 
347-373.
 2. Glehen O, Kwiatkowski F, Sugarbaker PH, et al. 
Cytoreductive surgery combined with perioperative intra-
peritoneal chemotherapy for the management of peritoneal 
carcinomatosis from colorectal cancer: a multi-institutional 
study. J Clin Oncol. 2004;22:3284-3292.
 3. Elias D, Lefevre JH, Chevalier J, et al. Complete cytore-
ductive surgery plus intraperitoneal chemohyperthermia 
with oxaliplatin for peritoneal carcinomatosis of colorectal 
origin. J Clin Oncol. 2009;27:681-685.
 4. Sugarbaker PH. Intraperitoneal chemotherapy and cytore-
ductive surgery for the prevention and treatment of perito-
neal carcinomatosis and sarcomatosis. Semin Surg Oncol. 
1998;14:254-261.
 5. Haringsma J, Tytgat GN, Yano H, et al. Autofluorescence 
endoscopy: feasibility of detection of GI neoplasms unap-
parent to white light endoscopy with an evolving technol-
ogy. Gastrointest Endosc. 2001;53:642-650.
 6. Vo-Dinh T, Panjehpour M, Overholt BF, Farris C, Buckley 
FP III, Sneed R. In vivo cancer diagnosis of the esophagus 
using differential normalized fluorescence (DNF) indices. 
Lasers Surg Med. 1995;16:41-47.
 7. Buchweitz O, Staebler A, Tio J, Kiesel L. Detection of peri-
toneal endometriotic lesions by autofluorescence laparos-
copy. Am J Obstet Gynecol. 2006;195:949-954.
 8. Kara MA, Bergman JJ. Autofluorescence imaging and 
narrow-band imaging for the detection of early neopla-
sia in patients with Barrett’s esophagus. Endoscopy. 
2006;38:627-631.
 9. Kara MA, Peters FP, Fockens P, ten Kate FJ, Bergman 
JJ. Endoscopic video- autofluorescence imaging fol-
lowed by narrow band imaging for detecting early 
neoplasia in Barrett’s esophagus. Gastrointest Endosc. 
2006;64:176-185.
 10. Li BH, Xie SS. Autofluorescence excitation-emission matri-
ces for diagnosis of colonic cancer. World J Gastroenterol. 
2005;11:3931-3934.
 11. Yeung TM, Mortensen NJ. Advances in endoscopic visualiza-
tion of colorectal polyps. Colorectal Dis. 2011;13:352-359.
 12. Ahmed T, Monti J, Lashner B. Random versus targeted 
biopsies for colorectal cancer surveillance in inflamma-
tory bowel disease. Gastroenterol Hepatol (N Y). 2010;6: 
438-442.
 13. Inoue K, Wakabayashi N, Morimoto Y, et al. Evaluation 
of autofluorescence colonoscopy for diagnosis of super-
ficial colorectal neoplastic lesions. Int J Colorectal Dis. 
2010;25:811-816.
 14. Matsumoto T, Nakamura S, Moriyama T, Hirahashi M, 
Iida M. Autofluorescence imaging colonoscopy for the 
detection of dysplastic lesions in ulcerative colitis: a pilot 
study. Colorectal Dis. 2010;12:e291-e297.
 15. Takeuchi Y, Inoue T, Hanaoka N, et al. Autofluorescence 
imaging with a transparent hood for detection of colorectal 
neoplasms: a prospective, randomized trial. Gastrointest 
Endosc. 2010;72:1006-1013.
 16. Haussinger K, Becker H, Stanzel F, et al. Autofluorescence 
bronchoscopy with white light bronchoscopy compared 
with white light bronchoscopy alone for the detection of 
precancerous lesions: a European randomised controlled 
multicentre trial. Thorax. 2005;60:496-503.
 17. Zheng W, Lau W, Cheng C, Soo KC, Olivo M. Optimal 
excitation-emission wavelengths for autofluorescence diag-
nosis of bladder tumors. Int J Cancer. 2003;104:477-481.
 at Universitatsbibliothek on August 25, 2016sri.sagepub.comDownloaded from 
von Breitenbuch et al 193
 18. Ronnett BM, Zahn CM, Kurman RJ, Kass ME, Sugarbaker 
PH, Shmookler BM. Disseminated peritoneal adeno-
mucinosis and peritoneal mucinous carcinomatosis: a 
clinicopathologic analysis of 109 cases with emphasis on 
distinguishing pathologic features, site of origin, prognosis, 
and relationship to “pseudomyxoma peritonei.” Am J Surg 
Pathol. 1995;19:1390-1408.
 19. Matsuda T, Saito Y, Fu KI, et al. Does autofluorescence 
imaging videoendoscopy system improve the colonoscopic 
polyp detection rate? A pilot study. Am J Gastroenterol. 
2008;103:1926-1932.
 20. Matsumoto T, Moriyama T, Yao T, Mibu R, Iida M. 
Autofluorescence imaging colonoscopy for the diagno-
sis of dysplasia in ulcerative colitis. Inflamm Bowel Dis. 
2007;13:640-641.
 21. van den Broek FJ, Fockens P, van Eeden S, et al. Endoscopic 
tri-modal imaging for surveillance in ulcerative colitis: 
randomised comparison of high-resolution endoscopy and 
autofluorescence imaging for neoplasia detection; and 
evaluation of narrow-band imaging for classification of 
lesions. Gut. 2008;57:1083-1089.
 22. Haussinger K, Stanzel F, Huber RM, Pichler J, Stepp H. 
Autofluorescence detection of bronchial tumors with the 
D-light/AF. Diagn Ther Endosc. 1999;5:105-112.
 23. Shibuya K, Fujisawa T, Hoshino H, et al. Fluorescence 
bronchoscopy in the detection of preinvasive bronchial 
lesions in patients with sputum cytology suspicious or posi-
tive for malignancy. Lung Cancer. 2001;32:19-25.
 24. Moro-Sibilot D, Jeanmart M, Lantuejoul S, et al. 
Cigarette smoking, preinvasive bronchial lesions, and 
autofluorescence bronchoscopy. Chest. 2002;122: 
1902-1908.
 25. Blonski W, Kundu R, Lewis J, Aberra F, Osterman M, 
Lichtenstein GR. Is dysplasia visible during surveillance 
colonoscopy in patients with ulcerative colitis? Scand J 
Gastroenterol. 2008;43:698-703.
 26. Rubin DT, Rothe JA, Hetzel JT, Cohen RD, Hanauer SB. 
Are dysplasia and colorectal cancer endoscopically visible 
in patients with ulcerative colitis? Gastrointest Endosc. 
2007;65:998-1004.
 27. Pomel C, Appleyard TL, Gouy S, Rouzier R, Elias D. The 
role of laparoscopy to evaluate candidates for complete 
cytoreduction of peritoneal carcinomatosis and hyper-
thermic intraperitoneal chemotherapy. Eur J Surg Oncol. 
2005;31:540-543.
 28. Contreras CM, Stanelle EJ, Mansour J, et al. Staging lapa-
roscopy enhances the detection of occult metastases in 
patients with pancreatic adenocarcinoma. J Surg Oncol. 
2009;100:663-669.
 29. Garofalo A, Valle M. Laparoscopy in the management of 
peritoneal carcinomatosis. Cancer J. 2009;15:190-195.
 30. Elias D, Honore C, Dumont F, et al. Results of systematic 
second-look surgery plus HIPEC in asymptomatic patients 
presenting a high risk of developing colorectal peritoneal 
carcinomatosis. Ann Surg. 2011;254:289-293.
 31. Bijelic L, Yan TD, Sugarbaker PH. Failure analysis of 
recurrent disease following complete cytoreduction and 
perioperative intraperitoneal chemotherapy in patients with 
peritoneal carcinomatosis from colorectal cancer. Ann Surg 
Oncol. 2007;14:2281-2288.
 at Universitatsbibliothek on August 25, 2016sri.sagepub.comDownloaded from 
